Literature DB >> 22876032

Impact of environmental and dietary factors on the course of inflammatory bowel disease.

Eduard Cabré1, Eugeni Domènech.   

Abstract

Besides their possible effects on the development of inflammatory bowel disease (IBD), some environmental factors can modulate the clinical course of both ulcerative colitis (UC) and Crohn's disease (CD). This review is mainly devoted to describing the current knowledge of the impact of some of these factors on the outcome of IBD, with special emphasis on smoking and diet. Although the impact of smoking on the susceptibility to develop CD and UC is firmly established, its influence on the clinical course of both diseases is still debatable. In CD, active smoking is a risk factor for postoperative recurrence. Beyond this clinical setting, smoking cessation seems to be advantageous in those CD patients who were smokers at disease diagnosis, while smoking resumption may be of benefit in ex-smokers with resistant UC. The role of dietary habits on the development of IBD is far from being well established. Also, food intolerances are very frequent, but usually inconsistent among IBD patients, and therefore no general dietary recommendations can be made in these patients. In general, IBD patients should eat a diet as varied as possible. Regarding the possible therapeutic role of some dietary components in IBD, lessons should be drawn from the investigation of the primary therapeutic effect of enteral nutrition in CD. Low-fat diets seem to be particularly useful. Also, some lipid sources, such as olive oil, medium-chain triglycerides, and perhaps omega-3 fatty acids, might have a therapeutic effect. Fermentable fiber may have a role in preventing relapses in inactive UC.

Entities:  

Keywords:  Dietary factors; Environmental factors; Infections; Inflammatory bowel disease; Nonsteroidal anti-inflammatory drugs; Smoking

Mesh:

Substances:

Year:  2012        PMID: 22876032      PMCID: PMC3413052          DOI: 10.3748/wjg.v18.i29.3814

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  113 in total

1.  Self-reported food intolerance in chronic inflammatory bowel disease.

Authors:  M Ballegaard; A Bjergstrøm; S Brøndum; E Hylander; L Jensen; K Ladefoged
Journal:  Scand J Gastroenterol       Date:  1997-06       Impact factor: 2.423

Review 2.  Enteral nutritional therapy for induction of remission in Crohn's disease.

Authors:  M Zachos; M Tondeur; A M Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study.

Authors:  Catarina Sousa Guerreiro; Marília Cravo; Ana Raimundo Costa; Ana Miranda; Lourdes Tavares; Paula Moura-Santos; Pedro MarquesVidal; Carlos Nobre Leitão
Journal:  Am J Gastroenterol       Date:  2006-08-04       Impact factor: 10.864

Review 4.  Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease?

Authors:  Linda A Feagins; Byron L Cryer
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

5.  A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group.

Authors:  M Feeney; A Ciegg; P Winwood; J Snook
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

6.  Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification.

Authors:  Marian C Aldhous; Hazel E Drummond; Niall Anderson; Linda A Smith; Ian D R Arnott; Jack Satsangi
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

7.  Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases.

Authors:  Rocco Ricciardi; James W Ogilvie; Patricia L Roberts; Peter W Marcello; Thomas W Concannon; Nancy N Baxter
Journal:  Dis Colon Rectum       Date:  2009-01       Impact factor: 4.585

8.  The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies.

Authors:  George E Reese; Theodore Nanidis; Catherine Borysiewicz; Takayuki Yamamoto; Timothy Orchard; Paris P Tekkis
Journal:  Int J Colorectal Dis       Date:  2008-09-02       Impact factor: 2.571

9.  Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's disease.

Authors:  David S Fefferman; Parag J Lodhavia; Mazen Alsahli; Kenneth R Falchuk; Mark A Peppercorn; Samir A Shah; Richard J Farrell
Journal:  Inflamm Bowel Dis       Date:  2004-07       Impact factor: 5.325

10.  Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.

Authors:  Preetika Sinh; Terrence A Barrett; Laura Yun
Journal:  Gastroenterol Res Pract       Date:  2011-09-12       Impact factor: 2.260

View more
  31 in total

Review 1.  Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease.

Authors:  Ashwin N Ananthakrishnan; Hamed Khalili; Gauree G Konijeti; Leslie M Higuchi; Punyanganie de Silva; Charles S Fuchs; Walter C Willett; James M Richter; Andrew T Chan
Journal:  Gut       Date:  2013-07-04       Impact factor: 23.059

2.  Role of Salmonella enterica exposure in Chilean Crohn's disease patients.

Authors:  Manuel Alvarez-Lobos; Daniela P Pizarro; Christian E Palavecino; Abner Espinoza; Valentina P Sebastián; Juan C Alvarado; Patricio Ibañez; Carlos Quintana; Orlando Díaz; Alexis M Kalergis; Susan M Bueno
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  Effects of endoplasmic reticulum stress on the expression of inflammatory cytokines in patients with ulcerative colitis.

Authors:  Nan Li; Xue-Ming Wang; Li-Jun Jiang; Meng Zhang; Na Li; Zhen-Zhen Wei; Nan Zheng; Ya-Jiao Zhao
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 4.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

5.  Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.

Authors:  José Miguel Luz Parente; Claudio Saddy Rodrigues Coy; Viriato Campelo; Mírian Perpétua Palha Dias Parente; Leonardo Araújo Costa; Renata Mendes da Silva; Celso Stephan; José Murilo Robilotta Zeitune
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 6.  Crucial steps in the natural history of inflammatory bowel disease.

Authors:  Giovanni Latella; Claudio Papi
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 7.  Diet therapy for inflammatory bowel diseases: The established and the new.

Authors:  Franziska Durchschein; Wolfgang Petritsch; Heinz F Hammer
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 8.  Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer.

Authors:  Kazuki Moro; Masayuki Nagahashi; Rajesh Ramanathan; Kazuaki Takabe; Toshifumi Wakai
Journal:  World J Clin Cases       Date:  2016-07-16       Impact factor: 1.337

9.  Perilla frutescens Britton var. frutescens leaves attenuate dextran sulfate sodium-induced acute colitis in mice and lipopolysaccharide-stimulated angiogenic processes in human umbilical vein endothelial cells.

Authors:  Yuna Lee; Jungjae Lee; Jihyeung Ju
Journal:  Food Sci Biotechnol       Date:  2019-11-25       Impact factor: 2.391

Review 10.  Environmental risk factors for inflammatory bowel diseases: a review.

Authors:  Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2014-09-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.